Day: March 22, 2024

LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JANUARY 31, 2024 Vancouver, March 22, 2024 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) announces results for the fiscal period ending January 31, 2024. All references to dollar amounts in this release are in Canadian dollars. Highlights During and After the Quarter During the three months ended January 31, 2024:On December 14, 2023, the company announced it has received further positive assay results for Co-Ni-Au from Gallery 7.  This second batch of  104 samples prolongate the zone of Co-Ni-Au-occurrences by about 250 m to a total length of roughly 400 m NNW-SSE, and constitute the central-southern part of G7 at the Bihor Sud project in Romania. Highlights include 6.7% Co, 13.0% Ni, 7.5...

Weekly Report (March 15-21, 2024) on the First Tranche of Stellantis 2024 Share Buyback Program AMSTERDAM, March 22, 2024 – Stellantis N.V. (“Stellantis” or the “Company”) announced today that pursuant to its First Tranche of the 2024 Share Buyback Program announced on February 28, 2024, covering up to €1 billion to be executed in the open market during the period between February 28, 2024 and June 5, 2024, it has repurchased the following common shares in the period between March 15 up to and including March 21, 2024:Date Number of Shares Repurchased Average Market Purchase Price in € per share Repurchased Volume in € (excluding fees) Venues19-march-24 164 495 €26.1981 €4 309 455.15 MI19-march-24 13 617 €26.1659 €356 300.88 CEUX21-march-24 2 274 116 €27.0148 €61 434 690.65 MITotal 2 452 228 €26.9553 €66 100 446.68  Since...

Dubai, UAE, March 22, 2024 (GLOBE NEWSWIRE) —  Lytus Technologies Holdings PTV. Ltd. (the “Company”) (Nasdaq:LYT), a leading global technology-driven services company, is pleased to invite investors to a webinar on March 27, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Lytus Technologies’ CEO, Dharmesh Pandya, who will share insight into the Company’s innovative platform, strategic positioning, and near-term growth trajectory, as well as the recent launch of Lytus Cloud, a cutting-edge suite of cloud infrastructure services with robust management capabilities. A live Q&A session with Pandya will follow the presentation. To register for the free webinar, please visit: https://redchip.zoom.us/webinar/register/WN_m5XHebKeSpeou-qxoWMilg Questions can be pre-submitted to LYT@redchip.com...

On  22 March 2024 Tomas Svidinskas is elected Chairman of the Board of Snaigė AB. General directorDarius VarnasPhone No. +370 315 56200

Sustainable Green Team (SGTM) Signs Memorandum of Understanding Agreement for Southeastern U.S. Waste Management Project– Sustainable Green Team, Inc. (OTCQX: SGTM) ($SGTM) (“SGTM” or “the Company”), announced signing a Memorandum of Understanding (MOU) agreement for a waste management project in the southeastern United States; joint parties expected to generate sales of approximately $100 million – https://thesustainablegreenteam.com/ORLANDO, Fla., March 22, 2024 (GLOBE NEWSWIRE) — Sustainable Green Team, Inc. (OTCQX: SGTM) ($SGTM) (“SGTM” or “the Company”), a leading provider of sustainable waste management solutions, announced signing a Memorandum of Understanding (MOU) agreement for a waste management project in the southeastern United States. The MOU, signed...

On 19 January 2024 it was announced that SKEL fjárfestingafélag hf. (“SKEL”) and Samkaup hf., id. 571298-3769 (“Samkaup”), had signed joint statement on the launch of exploratory negotiations toward a potential merger between Samkaup, Orkan IS ehf., Löður ehf., Heimkaup ehf., Lyfjaval ehf. When the joint statement was signed, it was agreed that the results of these negotiations would be finalized by 22 March 2024. However, since the negotiations between the parties are ongoing and still subject to the overall assessment of commercial and competitive considerations, the parties have agreed to continue exclusive negotiations until 15 May 2024. For more information, please contact Ásgeir Helgi Reykfjörð Gylfason at fjarfestar@skel.is.

To NASDAQ Copenhagen A/S   Executive Management Lersø Parkalle 100 DK-2100 København Ø www.rd.dk Telephone +45 7012 5300 22 March 2024Company announcement number 21/2024 Fixing of coupon rate effective from 1 April 2024With effect from 1 April 2024, the coupon rate of the following bonds financing RD Euribor3®, RD Stibor3®, RD Stibor3® Green, RD Nibor3®, RD Cibor6® (RO), FlexGaranti® and RenteDyk® will be adjusted.          Please find the data in the attached file. The Executive Board Any additional questions should be addressed to Chief Analyst Hella Gebhardt Rønnebæk, Phone +45 45 13 20 68.AttachmentsBilag til selskabsmeddelelse nr. 21-2024_ukNr. 21_Fastsaettelse af kuponrente pr. 01.04.2024_uk

EHang Announces Japan’s First UAM Center in TsukubaDuring the inauguration ceremony of UAM Center, EH216-S completed its debut flight in the Kanto region in Japan.EHang Announces Japan’s First UAM Center in TsukubaFrom left to right: Tatsuo Igarashi, mayor of Tsukuba City, Tetsuo Tanaka, Tsukuba Airlines COO, Tezuka Kiwamu, Founder and CEO of AirX, Conor Yang, CFO of EHangEHang Announces Japan’s First UAM Center in TsukubaEH216-S pilotless eVTOL successfully completed its debut flight in the Kanto region, JapanGUANGZHOU, China, March 22, 2024 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company, announced today that Japan’s first UAM Center has been established in Tsukuba City,...

BEDMINSTER, N.J., March 22, 2024 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces complete clinical response in three patients with serious invasive fusarium infection following treatment with MAT2203, Matinas’ oral formulation of the potent antifungal amphotericin B. All three patients were enrolled in the Company’s Compassionate/Expanded Use Access Program and were treated by Marisa H. Miceli, MD, Professor of Medicine, Specializing in Fungal Infections and Transplant Diseases, Division of Infectious Diseases, Internal Medicine, at the University of Michigan. “Invasive fusarium infection is often difficult to treat as clinically relevant fusarium...